<DOC>
	<DOCNO>NCT01851083</DOCNO>
	<brief_summary>Pediatric severe traumatic brain injury ( TBI ) lead cause death disability child age 1-14 year old . There effective therapy treat secondary brain injury post-injury response CNS apoptosis neuroinflammation . This study follow-up trial previously perform Phase I trial demonstrate safety potential CNS structural preservation effect intravenous autologous bone marrow mononuclear cell ( BMMNC ) severe TBI child . ( Cox , 2011 ) The study design prospective , randomize , placebo control , blind Phase 2 safety/biological activity study . The investigator hope determine effect intravenous infusion autologous BMMNCs brain structure neurocognitive/functional outcome severe TBI child .</brief_summary>
	<brief_title>Pediatric Autologous Bone Marrow Mononuclear Cells Severe Traumatic Brain Injury</brief_title>
	<detailed_description>Study Design : Multicenter , randomize , blind , placebo control , Bayesian adaptive dose escalation design . Study Intervention : Single dose administer within 48 hour time injury . Controls undergo sham harvest receive similarly labeled/external appearance volume 0.9 % NaCl . BMMNC 's harvest undergo process cGMP condition obtain 6x10^6 cells/kg 10x10^6 cells/kg weight . The cellular product/placebo infuse within 48 hour injury . Safety Monitoring &amp; Follow-Up : Subjects monitor infusion relate toxicity post-infusion hospital discharge follow-up return study visit . Laboratory image study repeat 1 , 6 , 12-month follow-up visit . A medical safety monitor ( MSM ) review blind SAE report follow post-infusion Day 14 subject real time ensure good clinical practice quickly identify safety concern . The MSM remain blinded treatment assignment , unless NINDS appoint DSMB approve unblinding .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<criteria>1 . Between 5 17 year age day injury , 2 . Glasgow Coma Score ( GCS ) 3 8 , ( best unmedicated postresuscitation score screening ) , 3 . Ability obtain legally authorize representative ( LAR ) consent , complete BMMNC/Sham harvest cell/placebo infusion within 48 hour initial injury , 4 . Ability speak English Spanish . 1 . Known history : a. previous brain injury , b. intellectual deficiency psychiatric condition , define inability independently function regular classroom may invalidate ability assess postinjury change cognition behavior ( ADHD and/or learn disability NOT exclusion ) , c. neurologic impairment and/or deficit , d. seizure disorder require anticonvulsant therapy , e. recently treat infection , f. renal disease alter renal function ( postresuscitation serum creatinine &gt; 1.5 mg/dL ) , g. hepatic disease alter liver function ( postresuscitation , noncontusion relate SGPT &gt; 150 Î¼/L and/or T. Bilirubin &gt; 1.3 mg/dL ) , h. cancer , i. immunosuppression define WBC &lt; 3 , 000 cells/ml admission , j. HIV+ , k. chemical ETOH dependency , l. history child abuse , m. premature birth ( &lt; 37 week GA/2500 gram ) result cognitive/physical disability and/or developmental delay . 2 . Obliteration perimesencephalic cistern initial head CT/MRI suggest prolonged hypoxic ischemic insult/herniation syndrome . 3 . Initial hospital ICP &gt; 40 mm Hg . 4 . Hemodynamic instability time screen define SBP &lt; 90 mmHg , ongoing fluid resuscitation and/or requirement inotropic support maintain MAP normal age include CPP base inotropic support . IVF alone exclude enrollment . 5 . Uncorrected coagulopathy time bone marrow harvest define INR &gt; 1.6 , PTT &gt; 38 sec ; PLT &lt; 100,000 ; Fibrinogen &lt; 100 g/dL . 6 . Unstable pelvic fracture define require early operative fixation . 7 . Pulmonary contusion define chest xray nonanatomic opacification and/or PaO2 : FiO2 ratio &lt; 250 associate mechanism injury . 8 . Greater AAST Grade 3 solid hollow visceral injury abdomen and/or pelvis diagnose CT image . 9 . Spinal cord injury diagnose CT/MR image clinical finding . 10 . Persistent hypoxia define SaO2 &lt; 94 % &gt; 30 minute occur time hospital admission time consent . 11 . Positive pregnancy test , applicable . 12 . Concurrent participation interventional drug/device research study . 13 . Unwillingness return followup visit . 14 . Contraindications MRI . 15 . Penetrating brain injury .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Traumatic Brain Injury</keyword>
	<keyword>TBI</keyword>
	<keyword>pediatric</keyword>
	<keyword>acute</keyword>
	<keyword>stem cell</keyword>
</DOC>